Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReBoot: FMT in Anorexia Nervosa
NCT05834010Phase 1Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Mar 2023
- Primary completion
- Jan 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fecal microbiome transplant in anorexia nervosa (AN), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoints: Feasibility of FMT in AN patients at 2 years and Preferred route of FMT at 2 years. Started Mar 2023; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT05834010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05834010.